BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 19102214)

  • 21. Positron emission tomography for radiation treatment planning.
    Grosu AL; Piert M; Weber WA; Jeremic B; Picchio M; Schratzenstaller U; Zimmermann FB; Schwaiger M; Molls M
    Strahlenther Onkol; 2005 Aug; 181(8):483-99. PubMed ID: 16044216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New trends in the evaluation and treatment of cervix cancer: the role of FDG-PET.
    Magné N; Chargari C; Vicenzi L; Gillion N; Messai T; Magné J; Bonardel G; Haie-Meder C
    Cancer Treat Rev; 2008 Dec; 34(8):671-81. PubMed ID: 18849119
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Additional value of MR/PET fusion compared with PET/CT in the detection of lymph node metastases in cervical cancer patients.
    Kim SK; Choi HJ; Park SY; Lee HY; Seo SS; Yoo CW; Jung DC; Kang S; Cho KS
    Eur J Cancer; 2009 Aug; 45(12):2103-9. PubMed ID: 19403303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Impact of computed tomography (CT) and 18F-deoxyglucose-coincidence detection emission tomography (FDG-CDET) image fusion for optimisation of conformal radiotherapy in non-small-cell lung cancers].
    Deniaud-Alexandre E; Touboul E; Lerouge D; Grahek D; Foulquier JN; Petegnief Y; Grès B; El Balaa H; Keraudy K; Kerrou K; Montravers F; Milleron B; Lebeau B; Talbot JN
    Cancer Radiother; 2005 Sep; 9(5):304-15. PubMed ID: 16087377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography.
    Billé A; Pelosi E; Skanjeti A; Arena V; Errico L; Borasio P; Mancini M; Ardissone F
    Eur J Cardiothorac Surg; 2009 Sep; 36(3):440-5. PubMed ID: 19464906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PET/CT imaging to guide cervical cancer therapy.
    Grigsby PW
    Future Oncol; 2009 Sep; 5(7):953-8. PubMed ID: 19792965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The diagnostic value of PET/CT scanning in patients with cervical cancer: a prospective study.
    Loft A; Berthelsen AK; Roed H; Ottosen C; Lundvall L; Knudsen J; Nedergaard L; Højgaard L; Engelholm SA
    Gynecol Oncol; 2007 Jul; 106(1):29-34. PubMed ID: 17482666
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of manual and automated interpretation of fused PET/CT data on esophageal target definitions in radiation planning.
    Hong TS; Killoran JH; Mamede M; Mamon HJ
    Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1612-8. PubMed ID: 19028285
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymph node metastasis in patients with clinical early-stage cervical cancer: detection with integrated FDG PET/CT.
    Sironi S; Buda A; Picchio M; Perego P; Moreni R; Pellegrino A; Colombo M; Mangioni C; Messa C; Fazio F
    Radiology; 2006 Jan; 238(1):272-9. PubMed ID: 16304090
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of early recurrence with 18F-FDG PET in patients with cervical cancer.
    Ryu SY; Kim MH; Choi SC; Choi CW; Lee KH
    J Nucl Med; 2003 Mar; 44(3):347-52. PubMed ID: 12620999
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Areas of high 18F-FDG uptake on preradiotherapy PET/CT identify preferential sites of local relapse after chemoradiotherapy for non-small cell lung cancer.
    Calais J; Thureau S; Dubray B; Modzelewski R; Thiberville L; Gardin I; Vera P
    J Nucl Med; 2015 Feb; 56(2):196-203. PubMed ID: 25572091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.
    Pötter R; Knocke TH; Fellner C; Baldass M; Reinthaller A; Kucera H
    Cancer Radiother; 2000; 4(2):159-72. PubMed ID: 10812362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Impact of PET/CT on precise radiotherapy planning for non-small cell lung cancer].
    Gong HY; Yu JM; Fu Z; Li BS; Li JB; Liu TH
    Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):54-7. PubMed ID: 16737623
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical implications of defining the gross tumor volume with combination of CT and 18FDG-positron emission tomography in non-small-cell lung cancer.
    Grills IS; Yan D; Black QC; Wong CY; Martinez AA; Kestin LL
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):709-19. PubMed ID: 17197120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparison between PET-CT and MRI in diagnosing nodal metastasis of nasopharyngeal carcinoma].
    Hu WH; Zhang GY; Liu LZ; Wu HB; Li L; Gao YH; Pan Y; Wang QS
    Ai Zheng; 2005 Jul; 24(7):855-60. PubMed ID: 16004815
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of posttherapy positron emission tomography with tumor response and survival in cervical carcinoma.
    Schwarz JK; Siegel BA; Dehdashti F; Grigsby PW
    JAMA; 2007 Nov; 298(19):2289-95. PubMed ID: 18029833
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of integrated positron emission tomography and computed tomography in the assessment of nodal spread in cases with non-small cell lung cancer.
    Tasci E; Tezel C; Orki A; Akin O; Falay O; Kutlu CA
    Interact Cardiovasc Thorac Surg; 2010 Feb; 10(2):200-3. PubMed ID: 19933240
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pattern and predictors of occult mediastinal lymph node involvement in non-small cell lung cancer patients with negative mediastinal uptake on positron emission tomography.
    Al-Sarraf N; Aziz R; Gately K; Lucey J; Wilson L; McGovern E; Young V
    Eur J Cardiothorac Surg; 2008 Jan; 33(1):104-9. PubMed ID: 17977738
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FDG-PET/CT-guided intensity modulated head and neck radiotherapy: a pilot investigation.
    Schwartz DL; Ford EC; Rajendran J; Yueh B; Coltrera MD; Virgin J; Anzai Y; Haynor D; Lewellen B; Mattes D; Kinahan P; Meyer J; Phillips M; Leblanc M; Krohn K; Eary J; Laramore GE
    Head Neck; 2005 Jun; 27(6):478-87. PubMed ID: 15772953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deferring planned neck dissection following chemoradiation for stage IV head and neck cancer: the utility of PET-CT.
    Nayak JV; Walvekar RR; Andrade RS; Daamen N; Lai SY; Argiris A; Smith RP; Heron DE; Ferris RL; Johnson JT; Branstetter BF
    Laryngoscope; 2007 Dec; 117(12):2129-34. PubMed ID: 17921898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.